186 related articles for article (PubMed ID: 8563080)
1. Longitudinal study of serum and cerebrospinal fluid (CSF) class-specific antibodies against Campylobacter jejuni and GM1 ganglioside in Guillain-Barré syndrome.
Kimura F; Ito T; Yuki N; Nakajima H; Tanaka T; Shinoda K; Ohsawa N
Intern Med; 1995 Oct; 34(10):1009-14. PubMed ID: 8563080
[TBL] [Abstract][Full Text] [Related]
2. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
Koga M; Yuki N; Takahashi M; Saito K; Hirata K
J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
[TBL] [Abstract][Full Text] [Related]
3. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
Tang J; Yuan J; Hao H
Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
[TBL] [Abstract][Full Text] [Related]
4. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
[TBL] [Abstract][Full Text] [Related]
5. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis.
Koga M; Yuki N; Hirata K
J Neuroimmunol; 1999 May; 96(2):245-50. PubMed ID: 10337924
[TBL] [Abstract][Full Text] [Related]
6. IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course.
Bech E; Orntoft TF; Andersen LP; Skinhøj P; Jakobsen J
J Neuroimmunol; 1997 Jan; 72(1):59-66. PubMed ID: 9003245
[TBL] [Abstract][Full Text] [Related]
7. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
[TBL] [Abstract][Full Text] [Related]
9. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).
Gregson NA; Rees JH; Hughes RA
J Neuroimmunol; 1997 Mar; 73(1-2):28-36. PubMed ID: 9058756
[TBL] [Abstract][Full Text] [Related]
10. Anti-ganglioside antibodies in patients with Guillain-Barré syndrome and Campylobacter jejuni infection.
Rees JH; Gregson NA; Hughes RA
J Infect Dis; 1995 Aug; 172(2):605-6. PubMed ID: 7622918
[No Abstract] [Full Text] [Related]
11. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
[TBL] [Abstract][Full Text] [Related]
12. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
[TBL] [Abstract][Full Text] [Related]
13. Seroreactivity to Campylobacter jejuni and gangliosides in patients with Guillain-Barré syndrome.
von Wulffen H; Hartard C; Scharein E
J Infect Dis; 1994 Oct; 170(4):828-33. PubMed ID: 7930724
[TBL] [Abstract][Full Text] [Related]
14. [Antibodies to ganglioside GM1 and Campylobacter jejuni in patients with Guillain-Barré syndrome].
Basta I; Suturkova L; Vujić A; Aleksić S; Poceva A; Paskoska A; Milenikova K; Trikić R; Apostolski S
Srp Arh Celok Lek; 2005; 133(3-4):123-8. PubMed ID: 16206698
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP
Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
[TBL] [Abstract][Full Text] [Related]
16. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome.
Jacobs BC; Endtz HP; van der Meché FG; Hazenberg MP; de Klerk MA; van Doorn PA
J Neuroimmunol; 1997 Oct; 79(1):62-8. PubMed ID: 9357448
[TBL] [Abstract][Full Text] [Related]
17. Immunoadsorption therapy in Guillain-Barré syndrome.
Hirai K; Kihara M; Nakajima F; Miyanomae Y; Yoshioka H
Pediatr Neurol; 1998 Jul; 19(1):55-7. PubMed ID: 9682887
[TBL] [Abstract][Full Text] [Related]
18. [Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies].
Attarian S; Bonnefoi-Kyriacou B; Gayraud D; Mignard P; Boucraut J; Pouget J; Viallet F
Rev Neurol (Paris); 1997 Apr; 153(3):205-8. PubMed ID: 9296136
[TBL] [Abstract][Full Text] [Related]
19. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
20. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
Rees JH; Gregson NA; Hughes RA
Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]